ロード中...
Lercanidipine attenuates angiotensin II-induced cardiomyocyte hypertrophy by blocking calcineurin-NFAT3 and CaMKII-HDAC4 signaling
Previous studies have demonstrated that lercanidipine, a calcium channel blocker, may protect against cardiac hypertrophy; however, the underlying mechanisms remain unclear. In the present study, the effects of lercanidipine on hypertrophy and the mechanisms involved were investigated. Cardiomyocyte...
保存先:
| 出版年: | Mol Med Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5646991/ https://ncbi.nlm.nih.gov/pubmed/28849081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.7211 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|